910: Biopharma companies have adapted their business and technology strategies to address the decreased demand for COVID-19 vaccines, shifting towards a more predictable, seasonal market. In this episode of Technovation, Peter High speaks with Brad Miller, Chief Information Officer of Moderna. Brad shares how Moderna is harnessing cutting-edge technologies like AI, machine learning, and cloud computing to revolutionize the pharmaceutical industry. As Moderna transitions from a COVID-19 vaccine-focused company to a diversified portfolio that includes oncology and rare disease treatments, Brad explains how digital transformation is powering advancements in R&D, manufacturing, and commercialization. He also highlights Moderna's internal learning academies, which ensure the workforce stays on the leading edge of digital and AI innovations. With a rich background that includes leadership roles at Capital One, Mastercard, and Amazon, Brad brings valuable insights into technology leadership in biotech. Tune in to discover how Moderna is shaping the future of medicine through technology.
Moderna’s Post-COVID-19 Strategy: CIO Brad Miller AI, Innovation, and Digital Transformation in Biotech | Technovation with Peter High (CIO, CTO, CDO, CXO Interviews) podcast - Listen or read transcript on Metacast
